NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
NeoGenomics (NASDAQ: NEO), a leading oncology testing services company, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's management team will engage in a fireside chat on Thursday, December 5, 2024, at 9:30 a.m. ET in New York City. The presentation will be available via live webcast, with a replay accessible through the company's Investor Relations website section at ir.neogenomics.com.
NeoGenomics (NASDAQ: NEO), un'azienda leader nei servizi di testing oncologico, ha annunciato la sua partecipazione alla 36a Conferenza Annuale sulla Salute di Piper Sandler. Il team di gestione dell'azienda parteciperà a una chiacchierata informale giovedì 5 dicembre 2024, alle 9:30 a.m. ET a New York City. La presentazione sarà disponibile tramite webcast dal vivo, con una registrazione accessibile attraverso la sezione Investor Relations del sito web dell'azienda all'indirizzo ir.neogenomics.com.
NeoGenomics (NASDAQ: NEO), una compañía líder en servicios de pruebas oncológicas, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. El equipo de gestión de la compañía participará en una charla informal el jueves 5 de diciembre de 2024, a las 9:30 a.m. ET en la ciudad de Nueva York. La presentación estará disponible a través de una transmisión web en vivo, con una repetición accesible a través de la sección de Relaciones con Inversores del sitio web de la compañía en ir.neogenomics.com.
NeoGenomics (NASDAQ: NEO), 선도적인 온콜로지 검사 서비스 회사가 Piper Sandler 제36회 연례 건강 회의에 참가한다고 발표했습니다. 회사의 경영진은 2024년 12월 5일 목요일 오전 9시 30분 ET에 뉴욕시에서 진행되는 대담에 참여합니다. 발표는 라이브 웹캐스트를 통해 제공되며, 회사의 투자자 관계 웹사이트 섹션인 ir.neogenomics.com에서 다시 보기로 접근 가능합니다.
NeoGenomics (NASDAQ: NEO), une entreprise leader dans les services de tests en oncologie, a annoncé sa participation à la 36e Conférence Annuelle de Santé de Piper Sandler. L'équipe de direction de l'entreprise participera à une discussion informelle le jeudi 5 décembre 2024 à 9h30 ET à New York. La présentation sera disponible via un webinaire en direct, avec un enregistrement accessible via la section Relations Investisseurs du site Web de l'entreprise à l'adresse ir.neogenomics.com.
NeoGenomics (NASDAQ: NEO), ein führendes Unternehmen im Bereich der onkologischen Testdienste, hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler angekündigt. Das Managementteam des Unternehmens wird am Donnerstag, den 5. Dezember 2024, um 9:30 Uhr ET in New York City an einem Gespräch teilnehmen. Die Präsentation wird über einen Live-Webcast verfügbar sein, mit einer Wiederholung, die über den Bereich Investor Relations der Website des Unternehmens unter ir.neogenomics.com zugänglich ist.
- None.
- None.
The presentation will be webcast live and accessible online via this link. A replay will be available on the Investor Relations section of the Company’s website at ir.neogenomics.com.
About NeoGenomics, Inc.
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus for physicians to help them diagnose and treat cancer. The Company’s Advanced Diagnostic Division also serves pharmaceutical clients in clinical trials and drug development.
Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241108197311/en/
Investor Contact
Kendra Sweeney
kendra.sweeney@neogenomics.com
Media Contact
Andrea Sampson
asampson@sampsonprgroup.com
Source: NeoGenomics, Inc.
FAQ
When is NeoGenomics (NEO) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch NeoGenomics (NEO) presentation at the Piper Sandler Conference?
What type of presentation will NeoGenomics (NEO) give at the Piper Sandler Healthcare Conference?
Where is the Piper Sandler Healthcare Conference featuring NeoGenomics (NEO) being held?
